article thumbnail

What to expect from PEGS Europe 2023: Day 1

Drug Discovery World

Avraham will present on empowering GITR-targeted agonistic antibody-based immunotherapy by Fc engineering, and Jia will present on promoting immune response of endothelial cells by Bevacizumab, providing insights into the role of anti-VEGF therapy in reprogramming the immunosuppressive tumour microenvironment. Claes Gustafsson, Ph.D,

article thumbnail

What to expect from PEGS Europe 2023: Day 3

Drug Discovery World

Enkelejda Miho, PhD, Professor, University of Applied Sciences and Arts Northwestern Switzerland, and Managing Director, aiNET, on: ‘The singular immune response to dengue and machine learning identification of antibodies in high-throughput sequences’.